Real-world evidence regulations are on the way

Richard Tadd Blog

The last decade has seen increasing emphasis worldwide on the importance of well-regulated, real-world data collection and analysis as a follow-up to clinical trials for new medicines and medical devices. China is now taking steps to make regulatory changes of its own in this area. On 7 January 2020, the National Medical Products Association (NMPA) released a paper entitled Guiding …

Concerns over US clinical trials as it is revealed only 41% of results are reported in accordance with new laws

Richard Tadd Industry News

In January 2017, the US passed new regulations to ensure that all clinical trials would have their results reported within one year of primary completion – with hefty fines of up to US$10,000 a day for those who failed to comply with the new rules. Despite this, a recent study published by The Lancet found that almost six in 10 …

‘Bureaucracy’ is one of the greatest threats to clinical research

Richard Tadd Industry News

In 2013, Christina Reith, fellow of The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians, lead authored a paper that addressed in no uncertain terms what effect red tape was having on clinical trials in Europe. Her conclusions were damning – that for academics engaged in carrying out randomised control trials, the most pressing of issues were those …

Discover the unmet medical needs in China

Richard Tadd Blog

Healthcare is a big topic in China at the moment, thanks to the Healthy China 2020 initiative, but there have been major reforms going on in the sector for the past 14 years as the government has sought to modernise the way disease is dealt with and radically upgrade its medical infrastructure. Part of this has involved acknowledging that there …

Why choose China for your next clinical trial?

Richard Tadd Blog

Are you looking for the right site for your next clinical trial? China may not have been on your radar, but with recent developments leading to a dramatic improvement in what it has to offer, it really should be. There are good reasons why more and more healthcare companies are choosing to work with Chinese CROs. Here are five you …